USPTO serial 79335642
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
Donna J. Bunton NIXON & VANDERHYE P.C.901 North Glebe Road, 11th FloorArlington, VA 22203UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use; diagnostic reagents for scientific or research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific or research use other than for medical use; nucleic acids for laboratory use; nucleic acid for laboratory use, namely, for use in nucleic acid amplification processes not for medical use; nucleic acid amplification reagents for scientific and research use; nucleic acid sequencing programs being nucleic acid sequences other than for medical and veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes, namely, chemicals for use in multiplying nucleic acid amounts; diagnostic kits consisting primarily of diagnostic reagents for scientific use being reagents for testing for selected bacteria, and also comprising specimen receptors being scientific research specimen collection devices in the nature of tubes and flasks for the collection of blood, sterile body fluids, and urine; diagnostic preparations for scientific purposes; chemical products for diagnostic use, namely, chemical preparations for analyses in laboratories, other than medical or veterinary purposes; chemical diagnostic reagents for scientific use; diagnostic preparations, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for medical purposes; medical diagnostic reagents; clinical diagnostic reagents for medical purposes; diagnostic preparations for medical purposes | ACTIVE | — |
| 009 | Scientific apparatus, namely, incubators being laboratory equipment, spectrophotometers for measuring relative DNA, RNA and protein, stirring devices for scientific and laboratory use; magnetic agitators for laboratory use, and light detectors for detecting and identifying chemical and biological substances not for medical purposes; probes for scientific purposes; scientific apparatus and instruments, namely, incubators being laboratory equipment, spectrophotometers for measuring relative DNA, RNA and protein, magnetic agitators for laboratory use; scientific, optical, measuring, signaling and checking apparatus and instruments, namely, incubators being laboratory equipment, spectrophotometers for measuring DNA, RNA and protein, magnetic agitators for laboratory use; scientific research and laboratory apparatus, namely, incubators being laboratory equipment, spectrophotometers for measuring DNA, RNA and protein, magnetic agitators for laboratory use, testing apparatus for diagnostic purposes other than medical, namely, apparatus for detection and identification of pathogens; scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signaling, checking, life-saving and teaching apparatus and instruments, namely, incubators being laboratory equipment, magnetic agitators for laboratory use, laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for testing food, diagnostic apparatus for the detection of pathogens for laboratory or research use; downloadable and recorded software for use in connection with the aforementioned scientific, research, laboratory apparatus and instruments, namely, incubators, spectrophotometers, stirring devices, agitators and light detectors for analyzing and interpreting signals from said apparatus; computer systems comprised of computers, computer peripherals, and recorded computer operating programs; infrared detection apparatus, not for medical purposes | ACTIVE | — |
| 010 | Medical diagnostic apparatus for testing being the detection of abnormal prion protein; medical diagnostic apparatus for testing being analyzing of bacteria in biological samples; medical diagnostic instruments for analyzing of bacteria in biological samples; tools for medical diagnostics, namely, diagnostic apparatus for analyzing of bacteria in biological samples; diagnostic apparatus for medical purposes for testing being analyzing of bacteria in biological samples; diagnostic, examination, and monitoring equipment for medical purposes, namely, for testing being the detection of abnormal prion protein and analyzing of bacteria in biological samples; testing instruments for medical diagnostic purposes, namely, for the detection of abnormal prion protein and analyzing of bacteria in biological samples; testing probes for medical diagnostic purposes; testing apparatus for medical purposes, namely, for analyzing of bacteria in biological samples | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 18, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 18, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 17, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 16, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 30, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 10, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 10, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 22, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 22, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 22, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 16, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 16, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 9, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 9, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 9, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 13, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 13, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 30, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 22, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 10, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |